REPL
Price
$7.50
Change
-$0.21 (-2.72%)
Updated
Jan 15, 12:05 PM (EDT)
Capitalization
604.8M
27 days until earnings call
Intraday BUY SELL Signals
VTYX
Price
$13.88
Change
+$0.02 (+0.14%)
Updated
Jan 15, 12:20 PM (EDT)
Capitalization
995.17M
63 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

REPL vs VTYX

Header iconREPL vs VTYX Comparison
Open Charts REPL vs VTYXBanner chart's image
Replimune Group
Price$7.50
Change-$0.21 (-2.72%)
Volume$127
Capitalization604.8M
Ventyx Biosciences
Price$13.88
Change+$0.02 (+0.14%)
Volume$596
Capitalization995.17M
REPL vs VTYX Comparison Chart in %
REPL
Daily Signal:
Gain/Loss:
VTYX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
REPL vs. VTYX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REPL is a Hold and VTYX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (REPL: $7.71 vs. VTYX: $13.86)
Brand notoriety: REPL and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REPL: 62% vs. VTYX: 68%
Market capitalization -- REPL: $604.8M vs. VTYX: $995.17M
REPL [@Biotechnology] is valued at $604.8M. VTYX’s [@Biotechnology] market capitalization is $995.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REPL’s FA Score shows that 1 FA rating(s) are green whileVTYX’s FA Score has 0 green FA rating(s).

  • REPL’s FA Score: 1 green, 4 red.
  • VTYX’s FA Score: 0 green, 5 red.
According to our system of comparison, VTYX is a better buy in the long-term than REPL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REPL’s TA Score shows that 5 TA indicator(s) are bullish while VTYX’s TA Score has 5 bullish TA indicator(s).

  • REPL’s TA Score: 5 bullish, 6 bearish.
  • VTYX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VTYX is a better buy in the short-term than REPL.

Price Growth

REPL (@Biotechnology) experienced а -13.57% price change this week, while VTYX (@Biotechnology) price change was +0.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.23%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +43.40%.

Reported Earning Dates

REPL is expected to report earnings on Feb 11, 2026.

VTYX is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (-0.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTYX($995M) has a higher market cap than REPL($605M). VTYX YTD gains are higher at: 53.488 vs. REPL (-20.679). VTYX has higher annual earnings (EBITDA): -115.4M vs. REPL (-298.27M). REPL has more cash in the bank: 324M vs. VTYX (193M). VTYX has less debt than REPL: VTYX (10M) vs REPL (76.3M). REPL (0) and VTYX (0) have equivalent revenues.
REPLVTYXREPL / VTYX
Capitalization605M995M61%
EBITDA-298.27M-115.4M258%
Gain YTD-20.67953.488-39%
P/E RatioN/AN/A-
Revenue00-
Total Cash324M193M168%
Total Debt76.3M10M763%
FUNDAMENTALS RATINGS
REPL: Fundamental Ratings
REPL
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
REPLVTYX
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
REPL
Daily Signal:
Gain/Loss:
VTYX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OCLVX20.140.06
+0.30%
Optimum Large Cap Value C
QIORX16.940.01
+0.06%
AQR International Momentum Style R6
BGALX16.65N/A
N/A
Baillie Gifford Global Alpha Equities 4
ICHKX16.95-0.01
-0.06%
Guinness Atkinson China & Hong Kong
NLSAX19.69-0.10
-0.51%
Neuberger Berman Long Short A

REPL and

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with NEVPF. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
-4.10%
NEVPF - REPL
64%
Loosely correlated
N/A
ELVAF - REPL
60%
Loosely correlated
N/A
IMNN - REPL
57%
Loosely correlated
-3.95%
SNDX - REPL
49%
Loosely correlated
+4.74%
KYMR - REPL
45%
Loosely correlated
+1.46%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with NMRA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then NMRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
N/A
NMRA - VTYX
41%
Loosely correlated
+0.47%
KYMR - VTYX
40%
Loosely correlated
+1.46%
GLUE - VTYX
39%
Loosely correlated
+0.29%
NAMS - VTYX
39%
Loosely correlated
+0.19%
REPL - VTYX
38%
Loosely correlated
-4.10%
More